絞り込み

16386

広告

Improving community prescribing of post-fracture denosumab after discharge.

著者 Wood H , Lewis H , Ward R , Solanki T , Fernando P
Br J Hosp Med (Lond).2017 Jan 02 ; 78(1):20-22.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (34view , 0users)
  • このエントリーをはてなブックマークに追加

Full Text Sources

Medical

In the UK, denosumab is usually started by hospital clinicians and continued by primary care physicians in the community, but in the authors' region denosumab is a 'green light' drug, only prescribed by the primary care team. The authors suspected that a proportion of patients who were recommended to start the drug after a neck of femur fracture were not receiving this on discharge. They aimed to improve the prescribing of denosumab by implementing a quality improvement project.
PMID: 28067568 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード